Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Inseego Corp INSG

Inseego Corp. is engaged in the designing and development of cloud-managed wireless wide area network (WAN) and intelligent edge solutions. Its 4G and 5G WAN portfolio is comprised of mobile broadband and fixed wireless access solutions with associated cloud solutions for real time WAN visibility, monitoring, automation and control with centralized orchestration of network functions. These solutions are built for the enterprise and small and medium business (SMB) market segments. Its intelligent edge telematics solutions are designed to improve business outcomes for enterprise and SMB markets. It also provides a wireless subscriber management solution for carriers' management of their government and enterprise customer subscriptions. Its 5G products and associated cloud solutions are used in applications, such as business broadband for both mobile and fixed use cases, enterprise networking and software-defined WAN failover management. Its mobile hotspots are sold under the MiFi brand.


NDAQ:INSG - Post by User

<< Previous
Bullboard Posts
Next >>
Post by MiaLandon Apr 16, 2022 3:27am
191 Views
Post# 34607259

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>